The life sciences industry is the most promising sector of the U.S. economy, having already yielded important breakthroughs in genomics, cell and gene therapies and gene editing, to name just a few. The coronavirus crisis has only accelerated interest in this space as there is now renewed attention to eradicating disease and improving population health, irrespective of COVID-19.
